MRPS36P1

Across TCGA pan-cancer cohorts, MRPS36P1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MRPS36P1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MRPS36P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MRPS36P1 expression acts as an unfavorable survival marker, although some lineages such as CESC and HNSC show a favorable association.

UVM, CESC, and OV are the cancer types where MRPS36P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Quartile	All	0.376	0.668	.002	80	view →
CESC	DFS	Median	II,III,IV	0.813	0.607	.005	70	view →
OV	DFS	Median	All	0.495	0.586	.004	36	view →
KICH	DFS	Median	All	0.685	0.970	.001	35	view →
HNSC	OS	Median	III,IV	0.727	0.595	.010	21	view →
DLBC	DFS	Median	All	0.571	1.000	.005	16	view →
THCA	DFS	Quartile	IV	0.701	1.000	.005	15	view →
MESO	OS	Tertile	III,IV	0.441	0.636	.024	13	view →
PAAD	OS	Tertile	II,III,IV	0.262	0.495	.010	12	view →
READ	OS	Quartile	IV	0.466	1.000	.006	12	view →
GBM	DFS	Tertile	All	0.352	0.181	.041	6	view →
UCS	OS	Median	IV	0.693	0.262	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MRPS36P1–UVM (DFS)

Open the UVM breakdown →